Filtered By:
Condition: Hives
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 79 results found since Jan 2013.
A Skin Patch Shows Promise in Treating Kids ’ Peanut Allergies
WASHINGTON — An experimental skin patch is showing promise to treat toddlers who are highly allergic to peanuts—training their bodies to handle an accidental bite.
Peanut allergy is one of the most common and dangerous food allergies. Parents of allergic tots are constantly on guard against exposures that can turn birthday parties and play dates into emergency room visits.
There is no cure. The only treatment is for children 4 and older who can consume a special peanut powder to protect against a severe reaction.
The patch, named Viaskin, aims to deliver that kind of treatment through the skin instead. In a maj...
Source: TIME: Health - May 11, 2023 Category: Consumer Health News Authors: LAURAN NEERGAARD—AP Tags: Uncategorized Diet & Nutrition healthscienceclimate wire Source Type: news
Severe Asthma Patients on Ways Their Doctors Could Improve Treatment
Approximately 25 million people in the U.S. have asthma, according to the Asthma and Allergy Foundation of America. While that number shows how common the condition has become, the severe form is more rare. An estimate from a September 2021 study in the Journal of Asthma and Allergy found that about 9% of people with asthma meet the criteria for severe asthma.
Severe asthma comes with significantly more challenges than regular asthma. People with this condition tend to experience more symptoms, including increased activity limitations, greater prevalence of heart disease, and lower lung function. Even with high doses of in...
Source: TIME: Health - February 7, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Disease healthscienceclimate Source Type: news
Profile of Urticaria in an Inner-city Pediatric Emergency Department (ED) and its Correlation with Food Allergy
Urticaria may be the first and only presenting sign of a food allergy. Literature reveals that blacks have a higher burden of food allergy when compared to their white counterparts. We aimed to determine factors associated with Pediatric ED visits for urticaria in a hospital serving a black population.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Vrinda Kumar, Caroline Basta, Maria-Anna Vastardi Source Type: research
Hospitalists Join in Sustainability Efforts
Ms. Wohlford is the director of sustainability for Carilion Clinic. The Roanoke, Va.-based health system has numerous awards and recognitions for its sustainability efforts that include everything from installing solar-power receptors to hiring sheep to keep the lawn. Carilion Clinic.
In a world transformed by environmental degradation and the effects of climate change, hospitals can be major generators of greenhouse gases, energy consumption, and waste. But they are also important centers for health and wellness promotion, not just for the patients they serve but also for staff and their communities. That is why a growi...
Source: The Hospitalist - October 3, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Practice Management Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
A 70-year-old healthy woman was referred to our hospital for chronic urticaria. She did not have a history of allergy, asthma, and rhinitis. She was initially diagnosed with α-gal-related urticaria based on an episode of delayed-type urticaria after eating red meat. The results of the intracutaneous allergen test for beef and pork were negative. Fluorenzyme immunoassays specific for IgE against α-gal, beef, and pork were also negative. She was diagnosed with an α-gal -unrelated red meat allergy following the reproduction of urticaria by a food challenge test. The patient was unresponsive to several drugs, including anti...
Source: Case Reports in Dermatology - September 6, 2021 Category: Dermatology Source Type: research
Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT)
Iran J Allergy Asthma Immunol. 2021 Aug 7;20(4):423-431.ABSTRACTThe urticaria control test (UCT) is a patient-reported outcome measure (PROM) for chronic urticaria (CU) patients. As a Persian version of the UCT was not available, the present research aimed to develop such a version, to test its reliability and validity as well as to evaluate urticaria control among Persian-speaking patients. This research was conducted at the Urticaria Centre of Reference and Excellence (UCARE) of Ghaem Hospital, Mashhad, Iran. In a first step, a linguistically validated Persian version of the UCT was developed through a structured forward...
Source: Iranian Journal of Allergy, Asthma and Immunology - August 22, 2021 Category: Allergy & Immunology Authors: Maryam Khoshkhui Karsten Weller Javad Fadaee Marcus Maurer Farahzad Jabbari Azad Maryam Emadzadeh Source Type: research
